UNSPSC 51271918: Leucinocaine mesilate or mesylate

This classification denotes an anesthetic agent with the molecular formula C17H28N2O2.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 72E501K01E, chemically known as 1-pentanol, 2-(diethylamino)-4-methyl-, 1-(4-aminobenzoate), methanesulfonate (1:1), but more generally known as leucinocaine mesylate, which bears US NIH Compound Identifier 101618. European Medicines Agency schedules leucinocaine mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08447MIG.

Most nations, for tariff purposes, schedule leucinocaine mesylate under HS 29224995. SMILES: CCN(CC)C(CC(C)C)COC(=O)C1CCC(CC1)N.CS(=O)(=O)O.

UNSPSC 51271918 Leucinocaine mesilate or mesylate is a Commodity code that frames state and local purchases of specific pharmaceutical active ingredients and finished generic products for distribution through cooperative purchasing networks and authorized wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary recent solicitation vehicle under this code. State and local governments acquire these products through cooperative agreements that establish pricing and supply chains with multiple authorized wholesalers—in the MMCAP case, AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—rather than direct procurement by individual agencies. Vendors supplying under this code must maintain current Good Manufacturing Practices (cGMP) certification, comply with the Drug Supply Chain Security Act (DSCSA), hold contractual relationships with at least two of the three authorized wholesalers, and provide detailed product specifications including National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage form, and manufacturing location.

The MMCAP RFP issued January 20, 2026, due March 26, 2026, serves participating state and local government facilities across Minnesota and Oregon and represents a multi-award cooperative vehicle rather than a single-jurisdiction procurement. Evaluation criteria weight price competitiveness at 75 percent, with the remaining points distributed across fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and acceptance of a 3 percent administrative fee (5 percent). No specific set-aside restrictions are identified in the available documentation. Vendors must maintain insurance coverage including commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000, and all products must possess expiration dates of at least one year from manufacture with minimum six-month shelf life. The contract term runs two years for new responders with optional extensions at MMCAP's discretion, while incumbent responders' amendments align with existing agreement expiration dates through June 30, 2028. All awarded products must be available in the marketplace by May 15, 2026, with resulting agreements effective July 1, 2026.